Ana Campos Codo 16
Author Footnotes
16 These authors contributed equally to this work.
Ana Campos Codo
Footnotes
16 These authors contributed equally to this work.
Affiliations
Search for articles by this author
Laboratory of Immunometabolism, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, SP, Brazil
Gustavo Gastão Davanzo 16
Author Footnotes
16 These authors contributed equally to this work.
Gustavo Gastão Davanzo
Footnotes
16 These authors contributed equally to this work.
Affiliations
Search for articles by this author
Laboratory of Immunometabolism, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, SP, Brazil
Lauar de Brito Monteiro 16
Author Footnotes
16 These authors contributed equally to this work.
Lauar de Brito Monteiro
Footnotes
16 These authors contributed equally to this work.
Affiliations
Search for articles by this author
Laboratory of Immunometabolism, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, SP, Brazil
Helder I. Nakaya
Helder I. Nakaya
Affiliations
Search for articles by this author
Department of Clinical and Toxicological analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil
Alessandro S. Farias
Alessandro S. Farias
Affiliations
Search for articles by this author
Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, SP, BrazilExperimental Medicine Research Cluster (EMRC), University of Campinas, SP, Brazil
Pedro Manoel M. Moraes-Vieira
Pedro Manoel M. Moraes-Vieira
Correspondence
Corresponding Author and Lead Contact: Prof. Pedro Manoel Mendes Moraes Vieira. Rua Monteiro Lobato, 255, Bl H, Instituto de Biologia, Universidade de Campinas, Campinas, Brazil, 13083-862.
Affiliations
Search for articles by this author
Laboratory of Immunometabolism, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, SP, BrazilObesity and Comorbidities Research Center (OCRC), University of Campinas, SP, BrazilExperimental Medicine Research Cluster (EMRC), University of Campinas, SP, Brazil
Highlights
- ● Elevated glucose levels regulate viral replication and cytokine production in monocytes
- ● Glycolysis sustains CoV-2-induced monocyte response and viral replication
- ● mtROS/HIF-1α is necessary for CoV-2 replication and monocyte cytokine production
- ● Monocyte-derived cytokines drive T cell dysfunction and lung epithelial death.
Summary
COVID-19 can result in severe lung injury. It remained to be determined why diabetic individuals with uncontrolled glucose levels are more prone to develop the severe form of COVID-19. The molecular mechanism underlying SARS-CoV-2 infection and what determines the onset of the cytokine storm found in severe COVID-19 patients are unknown. Monocytes/macrophages are the most enriched immune cell types in the lungs of COVID-19 patients and appear to have a central role in the pathogenicity of the disease. These cells adapt their metabolism upon infection and become highly glycolytic, which facilitates SARS-CoV-2 replication. The infection triggers mitochondrial ROS production, which induces stabilization of hypoxia-inducible factor-1α (HIF-1α) and consequently promotes glycolysis. HIF-1α-induced changes in monocyte metabolism by SARS-CoV-2 infection directly inhibit T cell response and reduce epithelial cell survival. Targeting HIF-1ɑ may have great therapeutic potential for the development of novel drugs to treat COVID-19.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.